Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial
T Petrella, C Copie-Bergman, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2021
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]
G Fossard, F Broussais, I Coelho, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial
T Petrella, C Copie-Bergman, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2021
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]
G Fossard, F Broussais, I Coelho, et al.
Page
of 3